Angiotensin II receptor blockade in diabetic nephropathy.
Andersen
Steen
S
Hagedorn Auditoriet, Steno Diabetes Center, Niels Steensens Vej 6, Gentofte, Denmark.
D000450:Aldosterone / Q000502:physiology; D000804:Angiotensin II / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007668:Kidney / Q000502:physiology / Q000503:physiopathology; D007678:Kidney Glomerulus / Q000502:physiology / Q000503:physiopathology; D011945:Receptors, Angiotensin / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D000450:Aldosterone